Microphone, The Market Online logo and The 5 Minute Investor Podcast logo. (Source: Stockhouse)

Welcome to episode 38 of The 5-Minute Investor Podcast, where Stockhouse columnists Jonathon Brown and me, Trevor Abes, each deliver a 2.5-minute stock profile related to recent news stories with investment implications. This week, we’re talking about Blackberry and Innodata, a pair of stocks optimally positioned to benefit from the world’s exponential adoption of AI technology.

Here are Jon’s show notes for episode 38:

Here are Trevor’s show notes:

Here’s the most recent trio of episodes:

Thanks for listening!

The 5-Minute Investor is on SpotifyYouTubeiHeartRadioPodbean, Stockhouse or wherever finer podcasts are found.

Join the discussion: Find out what investors are saying about AI stocks and The 5-Minute Investor Podcast on the BlackBerry Ltd. and Innodata Inc. Bullboards, and make sure to explore the rest of Stockhouse’s stock forums and message boards.

Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein.

For full disclaimer information, please click here.


More From The Market Online

@ the Bell: No joke! Markets rise as investors await key Middle East update

Canada’s main stock index moved higher on Wednesday as global markets climbed, encouraged by comments from...
The Market Online Video

Exploring a region with deep gold history and modern discovery potential

Hello, I’m Ricki Lee, and this is The Capital Compass. Today we’re heading to South America...
The Market Online Video

Consumer packaged goods company acquires beverage manufacturing facility

In this Capital Compass episode, Cizzle Brands discusses acquiring a beverage manufacturing facility, adding vertical integration, guaranteed customers, and a clearer path to profitability.
The Market Online Video

Developing a neurosciences platform with potential applications across several indications

In this Capital Compass episode, Marvel Biosciences outlines progress on MB-204, its neuroscience platform targeting autism, Rett syndrome, Fragile X, and Alzheimer’s disease ahead…